Expert consensus
10.4244/EIJ-D-22-00246
•
Oct 7, 2022
Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Association of Percutaneous Cardiovascular Interventions
Pruszczyk P, Klok F, Kucher N, Roik M, Meneveau N, Sharp AS, Nielsen-Kudsk J, Obradović S, Barco S, Giannini F, Stefanini G, Tarantini G, Konstantinides SV, Dudek D
free
Clinical research
10.4244/EIJ-D-21-01080
•
Oct 7, 2022
A pilot randomised trial of catheter-directed thrombolysis or standard anticoagulation for patients with intermediate-high risk acute pulmonary embolism
Kroupa J, Buk M, Weichet J, Malikova H, Bartova L, Linkova H, Ionita O, Kozel M, Motovska Z, Kocka V
free
Clinical research
10.4244/EIJ-D-22-00269
•
Oct 7, 2022
Evolocumab for prevention of microvascular dysfunction in patients undergoing percutaneous coronary intervention: the randomised, open-label EVOCATION trial
Ishihara M, Asakura M, Hibi K, Okada K, Shimizu W, Takano H, Suwa S, Fujii K, Okumura Y, Mano T, Tsujita K, Igeta M, Okamoto R, Suna S
free
Clinical research
10.4244/EIJ-D-21-01044
•
Oct 7, 2022
Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry
Chandrasekhar J, Baber U, Sartori S, Goel R, Nicolas J, Vogel B, Snyder C, Kini A, Briguori C, Witzenbichler B, Iakovou I, Sardella G, Marzo K, DeFranco A, Stuckey T, Chieffo A, Colombo A, Shlofmitz RA, Capodanno D, Dangas G, Pocock S, Mehran R
free
Clinical research
10.4244/EIJ-D-21-00971
•
Oct 7, 2022
Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries
Montone R, Rinaldi R, Del Buono M, Gurgoglione F, La Vecchia G, Russo M, Caffè A, Burzotta F, Leone AM, Romagnoli E, Sanna T, Pelargonio G, Trani C, Lanza GA, Niccoli G, Crea F
free
Clinical research
10.4244/EIJ-D-22-00305
•
Oct 7, 2022
Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial
Rader F, Kirtane AJ, Wang Y, Daemen J, Lurz P, Sayer J, Saxena M, Levy T, Scicli A, Thackeray L, Azizi M, Weber M
free
Clinical research
10.4244/EIJ-D-21-01036
•
Oct 7, 2022
Assessment of arterial stiffness to predict blood pressure response to renal sympathetic denervation
Fengler K, Rommel K, Kriese W, Kresoja K, Blazek S, Obradovic D, Feistritzer H, Lücke C, Gutberlet M, Desch S, Thiele H, Lurz P
free
Clinical research
10.4244/EIJ-D-22-00010
•
Sep 20, 2022
Urine alkalinisation to prevent contrast-induced acute kidney injury: the prospective, randomised, controlled, open-label TEATE trial
Lombardi M, Molisana M, Genovesi E, De Innocentiis C, Limbruno U, Misuraca L, Moretti † L, Di Vito L, Renda G, Zimarino M, Di Nicola M, De Caterina R
free
Showing
691
to
705
of
5343
results
